Nevertheless, the present analysis indicates that adiponectin level was independently associated with the risk of metabolic syndrome in chronic kidney disease patients after adjustment for confounding factors including eGFR and UACR. The gene discussed is ADIPOQ; the disease is metabolic syndrome.